LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $16,481,250
Key CONT_AWD_75N91019F00135_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 673 days before this system saw it. One version on record.
Cite this row
fc28dcca49b683f2cebb8210c7b5ad2c1c0f42b0062adf0acbafeebfc8542ad1The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $16,481,250 | first version | September 25, 2019 | November 1, 2024 | 2026-09-05T00:54:54Z | historical sweep | fc28dcca49b6 |
Archived copy
https://web.archive.org/web/20261012063342/https://www.usaspending.gov/award/CONT_AWD_75N91019F00135_7529_75N91019D00024_7529 captured by this system, October 12, 2026
What the amount is made of
10 recorded actions, so the amount is the award's current total across all of them. 5 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $16,481,250.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| November 1, 2024 | P00009 | OTHER ADMINISTRATIVE ACTION | no money | PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS |
| May 22, 2023 | P00008 | OTHER ADMINISTRATIVE ACTION | +$5,243,488 | PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS |
| May 3, 2023 | P00007 | OTHER ADMINISTRATIVE ACTION | no money | PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS |
| September 9, 2022 | P00006 | EXERCISE AN OPTION | +$3,759,526 | PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS |
| March 4, 2022 | P00005 | OTHER ADMINISTRATIVE ACTION | no money | PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS |
| November 18, 2021 | P00004 | OTHER ADMINISTRATIVE ACTION | no money | PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS |
| September 16, 2021 | P00003 | OTHER ADMINISTRATIVE ACTION | +$3,653,114 | PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS |
| November 6, 2020 | P00002 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | no money | PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS |
| September 25, 2020 | P00001 | EXERCISE AN OPTION | +$3,796,914 | PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS |
| September 25, 2019 | base | not on file | +$28,208 | PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS |
Last refreshed November 4, 2026 at 2:31 PM UTC.